Last updated on April 2019

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)


Brief description of study

An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

Detailed Study Description

Primary

To evaluate the long-term safety and tolerability of seladelpar

Secondary

To evaluate the long-term efficacy of seladelpar

Clinical Study Identifier: NCT03301506

Find a site near you

Start Over

Stanford Healthcare

Palo Alto, CA United States
  Connect »

Mercy Medical Center

Baltimore, MD United States
  Connect »

Saint Louis University

Saint Louis, MO United States
  Connect »

NYU Langone Health

New York, NY United States
  Connect »

Baylor College of Medicine

Houston, TX United States
  Connect »

Pinnacle Clinical Research

Live Oak, TX United States
  Connect »

Maryview Hospital Inc.

Newport News, VA United States
  Connect »

Plymouth Hospital

Plymouth, United Kingdom
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.